Non-alcoholic fatty liver disease (NAFLD) is a public health problem worldwide. This narrative Review provides an overview of the current literature to support notion that NAFLD multisystem disease. Convincing evidence shows strong association between and risk developing multiple extrahepatic complications such as type 2 diabetes, cardiovascular (ie, predominant cause mortality in people with N...

BACKGROUND Liver disease continues to be a major cause of morbidity and mortality in sub-Saharan Africa, including Nigeria, due to the high endemicity of viral hepatitis B. However non-alcoholic fatty liver disease may be an important contributory factor. The impact of fatty liver disease in our region has not been evaluated. AIM To determine the prevalence of non-alcoholic fatty liver diseas...

Non-alcoholic fatty liver disease (NAFLD) is becoming increasingly prevalent due to the worldwide obesity epidemic and currently affects one-third of adults or about one billion people worldwide. NAFLD is predicted to affect over 50% of the world's population by the end of the next decade. It is the most common form of liver disease and is associated with increased risk for progression to a mor...

background: non-alcoholic fatty liver disease (nafld) is increasingly a common disease which is created by the accumulation of fat in the liver. about 20% of adults and 5% of children suffer from this disease. in some studies, half of obese children had fatty liver disease and approximately 90% of the patients with fatty liver were obese. the aim of this study was to evaluate fatty liver diseas...

Non-alcoholic fatty liver disease (NAFLD) has become one of the top concerns for the practicing hepatogastroenterologist due to the obesity epidemic and it’s potential to progress to advanced liver disease which significantly impacts on overall and liver-related mortality. NAFLD may cause the liver to swell (steatohepatitis). An inflammation in liver may cause scarring (cirrhosis) over time and...

CONTEXT Non-alcoholic fatty liver disease (NAFLD), hepatic manifestation of metabolic syndrome, has been considered the most common liver disease nowadays, which is also the most frequent cause of elevated transaminases and cryptogenic cirrhosis. The greatest input of fatty acids into the liver and consequent increased beta-oxidation contribute to the formation of free radicals, release of infl...

Non-alcoholic fatty liver disease (NAFLD) consists of a range of complication. The disease describes clinical , para clinical and pathological conditions from simple steatosis in non-alcoholic steato hepatitis (NASH) to fibrosis, cirrhosis and hepato cellular carcinoma. Therefore, it is of interest to evaluate the grade of fatty liver and Liver Function Test in NAFLD patients. We collected samp...

Introduction: Nutrition as a modifiable risk factor that plays an important role in prevent or delay the onset of non-alcoholic fatty liver disease (NAFLD). Thus, the aim of the current study was to assess and compare physical activity, dietary fiber and sugar intake between non-alcoholic fatty liver disease and healthy individuals.Methods: The present case-con...

Background and objectives: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease caused by the accumulation of large amounts of fat in the hepatocytes. Given that atorvastatin is effective for treatment of NAFLD, the present study investigated effects of high-fat/fructose diet (HFFD) with atorvastatin on liver enzymes and lipid profile in a NAFLD rat model. Methods: Thirty-two m...